Dec 18 (Reuters) – Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S. drugmaker said on Thursday. The vaccine, mRNA-1018, would be the first mRNA-based bird flu vaccine to enter a pivotal trial, Moderna said. In May, the Trump … Continue reading Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition